These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 16076273)

  • 1. Nonpharmacologic stroke prevention in atrial fibrillation.
    Onalan O; Lashevsky I; Hamad A; Crystal E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.
    Möbius-Winkler S; Schuler GC; Sick PB
    Curr Opin Neurol; 2008 Feb; 21(1):64-9. PubMed ID: 18180653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpharmacologic approaches to stroke prevention in atrial fibrillation.
    Whitlock RP; Hanif H; Danter M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S79-86. PubMed ID: 23790602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Several alternatives for stroke prophylaxis in atrial fibrillation].
    Olsson SB
    Lakartidningen; 2004 Oct; 101(41):3156, 3158-9. PubMed ID: 15517711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical ablation of atrial fibrillation: the Columbia Presbyterian experience.
    Topkara VK; Williams MR; Cheema FH; Vigilance DW; Garrido MJ; Russo MJ; Oz MC; Argenziano M
    J Card Surg; 2006; 21(5):441-8. PubMed ID: 16948752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic-assisted left atrial ligation for stroke reduction in chronic atrial fibrillation: a case report.
    Kiaii B; McClure RS; Skanes AC; Ross IG; Spouge AR; Swinamer S; Rayman R; Bainbridge DT; Iglesias I; Novick RJ
    Heart Surg Forum; 2006; 9(1):E533-5; discussion E535. PubMed ID: 16387671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
    Han J; Cheng J; Mathuria N
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and stroke management: present and future.
    Holmes DR
    Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs.
    Lobodzinski SS
    Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
    Solomon MD; Ullal AJ; Hoang DD; Freeman JV; Heidenreich P; Turakhia MP
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):86-96. PubMed ID: 22193838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of stroke by percutaneous left atrial appendage closure: short term follow-up.
    De Meester P; Thijs V; Van Deyk K; Budts W
    Int J Cardiol; 2010 Jul; 142(2):195-6. PubMed ID: 19095320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Video-assisted epicardial ablation and left atrial appendage exclusion for atrial fibrillation: extended follow-up.
    Wudel JH; Chaudhuri P; Hiller JJ
    Ann Thorac Surg; 2008 Jan; 85(1):34-8. PubMed ID: 18154774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the Left Atrial Appendage in Atrial Fibrillation: Current State of the Art.
    Khawar W; Smith N; Masroor S
    Ann Thorac Surg; 2017 Dec; 104(6):2111-2119. PubMed ID: 28826990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous left atrial appendage closure therapy for the prevention of stroke.
    Blue Cross Blue Shield Asssociation
    Technol Eval Cent Assess Program Exec Summ; 2014 Oct; 29(5):1-4. PubMed ID: 25577826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.